AbCellera Biologics Inc. (ABCL)
Market Open
11 Sep, 14:07
$
10. 64
+0.18
+1.7686%
$
3.49B Market Cap
- P/E Ratio
- Div Yield
689,018 Volume
-0.47 Eps
$ 10.46
Previous Close 
Want to track ABCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AbCellera Biologics Inc. (ABCL) Statistics
Valuation metrics
Market Cap 3.49B
Enterprise value 3.51B
Trailing P/E (ttm) -21.17
Forward P/E -
PEG ratio 38.97
Price/Sales (ttm) 52.75
Price/Book (mrq) 3.9
Enterprise Value/Revenue 52.98
Enterprise Value/EBITDA -21.87
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.01M
Average volume (90 days) 6.05M
Price summary
52-Week low 2.75
52-Week high 12.58
Beta -
50-Day moving average 6.33
200-Day moving average 4.52
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.49%
Operating margin -3.4%
Operational effectiveness
Return on assets -0.13%
Return on equity -0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.77
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 12.77%
Book value per share (mrq) 2.93
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
